Skip to main content
DYN filings

Corporate insider profile

Jason P Rhodes Filing Activity

Latest reported as Director of Dyne Therapeutics, Inc. (DYN).

Purchase filings
0
Reported companies
1
Net open-market value
-$129,095,824.58
Latest transaction
Aug 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 14, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale2,586,928$25.20$65,184,894
Jul 7, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale777,451$22.97$17,858,516
Jun 29, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale504,695$21.23$10,712,555